EXIM PHARMA (Private limited company)

BE 0773.362.489 Active ●Avenue Louise 231, 1050 Bruxelles

EXIM PHARMA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0773.362.489. It was founded on 31-08-2021. Its registered office is in Brussels. Its main activity is: Wholesale trade. Its annual accounts for 2025 report equity of € -546 144 and a loss of € 190 058. Addrly gives it a financial health grade of E, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for 3 of its last 4 financial years.

Information last updated on 18-10-2026.

Company information

Status
Active
Enterprise number
BE 0773.362.489
VAT registered
Yes
Founded
31-08-2021
Latest accounts
2025
Employees
-
Region
Brussels-Capital
Establishments
1
Filing record
On time 3 of 4 years
Peppol e-invoicing
Registered
Registered office
Avenue Louise 231, 1050 Bruxelles
Main activity
Wholesale trade
NACE activities
46389 Commerce de gros d'autres produits alimentaires nca
46450 Commerce de gros de parfumerie et de produits de beauté
46460 Commerce de gros de produits pharmaceutiques et médicaux
46649 Commerce de gros d'autres machines et équipements nca
70200 Activités de conseil pour les affaires et autre conseil de gestion

Key figures of EXIM PHARMA

2025202420232022
Profit / loss
iWhat the period earned after taxes. A negative amount is a loss.
€ -190 058-44 %€ -131 949+18 %€ -160 090-40 %€ -114 047
Equity
iWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company.
€ -546 144-53 %€ -356 086-59 %€ -224 137-250 %€ -64 047
Total assets
iEverything the company owns. Equal to total equity and liabilities, which says how it is financed.
€ 354 353+40 %€ 252 543+123 %€ 113 472+118 %€ 52 080
Gross margin
iSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else.
€ -85 390-31 %€ -65 144+38 %€ -104 358+8 %€ -113 569
Employees (FTE)
iAverage number of workers over the period, in full-time equivalents.
----

Financial estimate

Financial health grade E, on a scale from A (safest) to E (most at risk)
Health barometer
The failure probability and the indicators behind this grade are visible with a free account.
Create a free account
Illustrative preview
Detected events
Appointments, capital, registered office, proceedings, extracted from the official acts.
Create a free account
Illustrative preview
Directors & mandates
2 mandates on record in the annual accounts. 1 of them started since 2024.
Create a free account

Similar companies

Other companies in the same activity in Brussels.

CompanyTown
FACQ 1050 Ixelles
COURIR BELGIUM 1050 Ixelles
LES PETITS RIENS - SPULLENHULP 1050 Ixelles
SWAROVSKI BELGIUM 1050 Ixelles
LONGCHAMP BENELUX 1050 Ixelles
Gant Belgium 1050 Ixelles
Comax 1050 Bruxelles
NATAN 1050 Ixelles
Looking for more information about EXIM PHARMA?
The free plan gives you 20 complete company dossiers every month, no card required: health barometer, directors, company links and detected events.
Create a free account

Frequently asked questions

Is EXIM PHARMA still active? Yes. The Crossroads Bank for Enterprises lists EXIM PHARMA as active.

What is the VAT number of EXIM PHARMA? The VAT number of EXIM PHARMA is BE 0773.362.489.

When was EXIM PHARMA founded? EXIM PHARMA was founded on 31-08-2021.

What is the address of EXIM PHARMA? The current registered office of EXIM PHARMA is Avenue Louise 231, 1050 Bruxelles.

When did EXIM PHARMA last file annual accounts? The latest annual accounts of EXIM PHARMA were filed on 12-10-2026.

Does EXIM PHARMA file its annual accounts on time? EXIM PHARMA filed its annual accounts within the legal deadline for 3 of its last 4 financial years. Late: 2025.

Is EXIM PHARMA financially healthy? Addrly gives EXIM PHARMA a financial health grade of E, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.

Is EXIM PHARMA profitable? The annual accounts of EXIM PHARMA for 2025 show a loss of € 190 058.

What is the equity of EXIM PHARMA? The equity of EXIM PHARMA was € -546 144 at the close of the 2025 financial year.

Who are the directors of EXIM PHARMA? The annual accounts of EXIM PHARMA record 2 mandates. The names, roles and dates are visible with a free account.

Can EXIM PHARMA receive Peppol e-invoices? Yes. EXIM PHARMA is registered on the Peppol network and can receive structured electronic invoices.

What does EXIM PHARMA do? The main activity of EXIM PHARMA is: Wholesale trade.

Sources

How Addrly builds and refreshes this data